13:36 , Sep 14, 2017 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: August 2017

New Therapeutic Targets and Biomarkers: August 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during August 2017. Therapeutic targets are defined as any protein, gene or other...
18:40 , Aug 9, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Brain cancer Patient sample, cell culture and mouse studies suggest inhibiting integrin α 7 could help treat glioblastoma multiforme (GBM). In patient samples, high tumor levels of integrin α 7 were associated with tumor...
08:00 , Dec 19, 2013 |  BC Innovations  |  Translation in Brief

Translational tidbits

Consorting with academia GlaxoSmithKline plc has set up an immuno-oncology consortium that invites academics from six cancer centers to view its nonpublic early pipeline programs and share ideas for new therapeutic candidates. The Oncology Clinical...
07:00 , Apr 9, 2012 |  BC Week In Review  |  Clinical News

Bariatric surgery: Phase II/III data

Researchers at the university and colleagues reported data from an open-label, Italian Phase II/III trial in 60 Type II diabetics aged 30-60 with a body mass index (BMI) >=35 showing that both gastric bypass and...